A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : cRGD / cyclic RGD

[Related PubMed/MEDLINE]
Total Number of Papers: 29
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   cRGD  (>> Co-occurring Abbreviation)
Long Form:   cyclic RGD
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Problem of Diminished cRGD Surface Activity and What Can Be Done about It. FCS, SPR
2018 A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors. ---
2018 Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis. ---
2018 Enhanced Intercellular Delivery of cRGD-siRNA Conjugates by an Additional Oligospermine Modification. siRNA
2017 Highly sensitive SERS analysis of the cyclic Arg-Gly-Asp peptide ligands of cells using nanogap antennas. SERS
2017 Water-Solubilizing Hydrophobic ZnAgInSe/ZnS QDs with Tumor-Targeted cRGD-Sulfobetaine-PIMA-Histamine Ligands via a Self-Assembly Strategy for Bioimaging. EPR, QDs, RES, SPH
2016 A Tunable Scaffold of Microtubular Graphite for 3D Cell Growth. AG, PEG
2016 Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy. DOX, NIR
2016 RGD-decorated redox-responsive d-alpha-tocopherol polyethylene glycol succinate-poly(lactide) nanoparticles for targeted drug delivery. AUC, NPs, PTX, TPGS-SS-PLA
10  2016 Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles. cRGD-uPIC-AuNP, LA, siRNA
11  2015 Density-tunable conjugation of cyclic RGD ligands with polyion complex vesicles for the neovascular imaging of orthotopic glioblastomas. MRI, PEGylated, PICsomes, SPIO
12  2015 In vitro and ex vivo hemocompatibility of off-the-shelf modified poly(vinyl alcohol) vascular grafts. PVA
13  2015 Monocyte mediated brain targeting delivery of macromolecular drug for the therapy of depression. cRGDL, TFF3
14  2015 Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells. DDS, siRNA, TECs
15  2014 Cyclic RGD peptide incorporation on phage major coat proteins for improved internalization by HeLa cells. ---
16  2014 Enhancement of antifungal activity by integrin-targeting of branched histidine rich peptides. ---
17  2014 Multifunctional polyion complex micelle featuring enhanced stability, targetability, and endosome escapability for systemic siRNA delivery to subcutaneous model of lung cancer. Chol, PEG, Plk1, siRNA, TEP, TEP
18  2014 Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. ECs, HUVECs, miR-132, NPs
19  2013 Characteristics of oncolytic vesicular stomatitis virus displaying tumor-targeting ligands. LDLR, VSV
20  2013 Multifunctional gold nanostar conjugates for tumor imaging and combined photothermal and chemo-therapy. NIR
21  2013 Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition. ---
22  2012 (111)In- and (203)Pb-Labeled Cyclic RGD Peptide Conjugate as an alpha(v)beta(3) Integrin-Binding Radiotracer. ---
23  2012 Bimolecular integrin-ligand interactions quantified using peptide-functionalized dextran-coated microparticles. ---
24  2012 Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor. ---
25  2012 Peptide-decorated liposomes promote arrest and aggregation of activated platelets under flow on vascular injury relevant protein surfaces in vitro. CBP, VBP
26  2012 Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces. ---
27  2011 Magnetic resonance imaging contrast agent: cRGD-ferric oxide nanometer particle and its role in the diagnosis of tumor. MRI, USPIO
28  2007 Preparation and evaluation of glycosylated arginine-glycine-aspartate (RGD) derivatives for integrin targeting. ---
29  2001 Integrin alpha(v)beta(3) is involved in stimulated migration of vascular adventitial fibroblasts by basic fibroblast growth factor but not platelet-derived growth factor. bFGF, PDGF, VAFs